Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2016-04-25 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CAGNES-SUR-MER (06800), Alpes-Maritimes
NOUVELLE PHARMACIE DES BOULEVARDS : revenue, balance sheet and financial ratios
NOUVELLE PHARMACIE DES BOULEVARDS is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CAGNES-SUR-MER (06800),
this company of category PME
shows in 2023 a revenue of 5.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - NOUVELLE PHARMACIE DES BOULEVARDS (SIREN 819889023)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
5 337 928 €
5 778 266 €
4 897 177 €
4 259 733 €
N/C
3 843 252 €
2 198 692 €
Net income
560 956 €
399 541 €
761 660 €
482 185 €
430 345 €
476 584 €
446 041 €
34 282 €
EBITDA
N/C
572 340 €
950 284 €
605 486 €
592 407 €
N/C
675 554 €
37 080 €
Net margin
N/C
7.5%
13.2%
9.8%
10.1%
N/C
11.6%
1.6%
Revenue and income statement
In 2024, NOUVELLE PHARMACIE DES BOULEVARDS generates positive net income of 561 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 34 k€ -> 561 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
560 956 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 41%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 60%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
40.909%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
60.201%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution NOUVELLE PHARMACIE DES BOULEVARDS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
480.202
245.528
146.947
101.081
77.967
59.475
47.674
40.909
Financial autonomy
15.362
24.507
36.748
44.568
49.078
53.594
58.52
60.201
Repayment capacity
79.862
5.489
None
4.445
3.457
1.912
2.731
None
Cash flow / Revenue
1.46%
11.41%
None%
10.076%
9.992%
13.084%
8.224%
None%
Sector positioning
Debt ratio
40.912024
2021
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good
In 2024, the debt ratio of NOUVELLE PHARMACIE DES BO... (40.91) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
60.2%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good
In 2024, the financial autonomy of NOUVELLE PHARMACIE DES BO... (60.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
2.73 years2023
2021
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Good+8 pts over 2 years
In 2023, the repayment capacity of NOUVELLE PHARMACIE DES BO... (2.73) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 232.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
232.842
Liquidity indicators evolution NOUVELLE PHARMACIE DES BOULEVARDS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
198.348
195.646
279.528
290.156
248.878
228.873
236.146
232.842
Interest coverage
39.369
3.142
None
2.683
2.27
1.344
2.431
None
Sector positioning
Liquidity ratio
232.842024
2021
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good
In 2024, the liquidity ratio of NOUVELLE PHARMACIE DES BO... (232.84) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
2.43x2023
2021
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Average+10 pts over 2 years
In 2023, the interest coverage of NOUVELLE PHARMACIE DES BO... (2.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution NOUVELLE PHARMACIE DES BOULEVARDS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Operating WCR
180 886 €
-68 948 €
0 €
306 062 €
221 450 €
141 625 €
397 782 €
0 €
Inventory turnover (days)
31
16
0
18
16
15
14
0
Customer payment term (days)
5
5
0
3
5
4
3
0
Supplier payment term (days)
56
36
0
40
41
38
41
0
Positioning of NOUVELLE PHARMACIE DES BOULEVARDS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of NOUVELLE PHARMACIE DES BOULEVARDS is estimated at
7 831 360 €
(range 5 453 635€ - 11 716 163€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
5453k€7831k€11716k€
7 831 360 €Range: 5 453 635€ - 11 716 163€
NAF 5 année 2024
Valuation method used
Net Income Multiple
560 956 €
×
14.0x
=7 831 360 €
Range: 5 453 636€ - 11 716 163€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare NOUVELLE PHARMACIE DES BOULEVARDS with other companies in the same sector:
Frequently asked questions about NOUVELLE PHARMACIE DES BOULEVARDS
What is the revenue of NOUVELLE PHARMACIE DES BOULEVARDS ?
The revenue of NOUVELLE PHARMACIE DES BOULEVARDS in 2023 is 5.3 M€.
Is NOUVELLE PHARMACIE DES BOULEVARDS profitable?
Yes, NOUVELLE PHARMACIE DES BOULEVARDS generated a net profit of 561 k€ in 2024.
Where is the headquarters of NOUVELLE PHARMACIE DES BOULEVARDS ?
The headquarters of NOUVELLE PHARMACIE DES BOULEVARDS is located in CAGNES-SUR-MER (06800), in the department Alpes-Maritimes.
Where to find the tax return of NOUVELLE PHARMACIE DES BOULEVARDS ?
The tax return of NOUVELLE PHARMACIE DES BOULEVARDS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does NOUVELLE PHARMACIE DES BOULEVARDS operate?
NOUVELLE PHARMACIE DES BOULEVARDS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart